• The Global HIV Vaccine Enterprise

    Uniting stakeholders to share knowledge, foster collaboration, enable solutions and expand support critical to the development of—and future access to—an HIV vaccine

    Learn moreStrategic Plan
    Diagram of the plan

A renewed Strategic Plan

Uniting stakeholders to share knowledge, foster collaboration, enable solutions and to support the most critical issues, risks and challenges faced by the field

Increasing resources

Mobilizing new funding to support and grow the field of HIV vaccine research and development

Greater collaboration

Promoting more efficient, faster ways for researchers to share successes and failures and avoid duplication of efforts

News

Meeting Report: Sustaining and strengthening HIV vaccine R&D in Europe

/in , /by

The Global HIV Vaccine Enterprise (the Enterprise) meeting in Ghent, Belgium, provided an opportunity to engage as a region on critical issues, including political and research commitments in Europe, with the aim of ensuring that HIV vaccine R&D remains a key priority in a challenging and changing global health landscape.

Read more

Upcoming event

Enterprise Workshop – Kigali 2019

/1 Comment/in /by

Are you an African researcher or a clinician working on HIV vaccine research and development (R&D)? Are you interested in sharing your experience and the challenges you face in your daily work? Are you keen to develop practical solutions to support African researchers towards the development of a safe and effective HIV vaccine?

The Global HIV Vaccine Enterprise invites you to apply to attend an interactive half-day workshop in Kigali.

Read more

Timely topics

In 2012, the Enterprise launched Timely Topics in HIV Vaccines, a strategy series convening experts as rapidly as possible to analyze, address, and respond to unresolved and emerging priority issues in the field. Through an open call for proposals, the Enterprise is working to identify the most important strategic needs of the field and sponsoring think tanks, meetings, forums and other events to tackle these issues.
Submit a timely topic

Portfolio

Newsletter

Sign up to receive the latest news of the Vaccine Enterprise and occasional information related to IAS activities related to vaccine research and development (Please read our Privacy Policy)

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

OKLearn more